Mobile Health Strategy for Premature Birth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a mobile app, PretermConnect, can reduce the risk of another preterm birth by enhancing health care engagement and care coordination. The trial compares this app-based approach to traditional paper-based health education typically provided to mothers. Women who have had a preterm baby and possess a mobile phone suitable for app downloads may qualify for this study. Participants must also have a child currently in the neonatal intensive care unit or have recently had a preterm baby. As an unphased trial, this study allows participants to contribute to innovative research that could improve future care for mothers and babies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the PretermConnect App is safe for use in reducing preterm births?
Research has shown that mobile apps like PretermConnect are designed to assist and educate mothers of premature babies. While specific safety details for the PretermConnect app are not provided in the studies, mobile health apps are generally considered safe. These apps aim to improve health outcomes without introducing new drugs or complex procedures.
The absence of a specific trial phase for PretermConnect indicates a focus on enhancing patient care and education. This suggests a lower risk of side effects compared to trials involving new medications. Overall, digital tools like PretermConnect are typically well-received and aim to provide support and information to help reduce preterm births.12345Why are researchers excited about this trial?
Researchers are excited about the PretermConnect App because it offers a fresh approach to delivering health education for managing premature birth risks. Unlike the traditional paper-based methods, this app provides information directly to a user's smartphone, making it more accessible and engaging. This digital delivery method allows for real-time updates and personalized content, which could lead to better understanding and adherence to health guidelines for expectant mothers. By leveraging technology, this app has the potential to enhance maternal education in a more efficient and user-friendly way.
What evidence suggests that the PretermConnect App is effective for reducing preterm births?
Studies have shown that mobile health apps like PretermConnect can benefit mothers and their preterm babies. In this trial, one group of participants will receive health education through the PretermConnect app. This app is designed to increase patient involvement and improve care coordination, potentially lowering the risk of another preterm birth. Research indicates that digital tools can better meet the needs of mothers and babies compared to traditional methods. By offering timely health education and support, PretermConnect aims to reduce early births and improve infant survival rates. Overall, early findings suggest that mobile health strategies can help reduce risks associated with preterm births.12346
Who Is on the Research Team?
C. Jason Wang, MD, PhD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for women aged 16-50 who have had a preterm infant and own a mobile phone. They must be able to read and understand English, with their child previously in neonatal care due to premature birth. Women without prior preterm births or those without a mobile phone are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive health education via a mobile app or paper-based strategy to reduce the risk of recurrent preterm births
Follow-up
Participants are monitored for outcomes such as inter-pregnancy interval, postpartum depression, and mother-infant bonding
What Are the Treatments Tested in This Trial?
Interventions
- Use of PretermConnect App
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
University of Pittsburgh Medical Center
Collaborator
Children's Hospital of Philadelphia
Collaborator